Home

Събиране на листа Финансови средства 鍔 chan carter 2010 nature reviews immunol 10 301 идентификация паша разнообразие

Antibody-dependent fragmentation is a newly identified mechanism of cell  killing in vivo | Scientific Reports
Antibody-dependent fragmentation is a newly identified mechanism of cell killing in vivo | Scientific Reports

Preferential Presentation of High-Affinity Immune Complexes in Germinal  Centers Can Explain How Passive Immunization Improves the Humoral Response  - ScienceDirect
Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect

Frontiers | Mass Cytometry Imaging for the Study of Human  Diseases—Applications and Data Analysis Strategies | Immunology
Frontiers | Mass Cytometry Imaging for the Study of Human Diseases—Applications and Data Analysis Strategies | Immunology

Cancer systems immunology | eLife
Cancer systems immunology | eLife

Microfluidic single-cell technology in immunology and antibody screening -  ScienceDirect
Microfluidic single-cell technology in immunology and antibody screening - ScienceDirect

PDF) Techniques to Study Antigen-Specific B Cell Responses
PDF) Techniques to Study Antigen-Specific B Cell Responses

Therapeutic antibodies for autoimmunity and inflammation | Nature Reviews  Immunology
Therapeutic antibodies for autoimmunity and inflammation | Nature Reviews Immunology

Preferential Presentation of High-Affinity Immune Complexes in Germinal  Centers Can Explain How Passive Immunization Improves the Humoral Response  - ScienceDirect
Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect

RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in  Preclinical Models of Acute Inflammation and Autoimmune Disease | Molecular  Pharmacology
RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease | Molecular Pharmacology

Targeting cytokines in disease | Nature Immunology
Targeting cytokines in disease | Nature Immunology

Microfluidic single-cell technology in immunology and antibody screening -  ScienceDirect
Microfluidic single-cell technology in immunology and antibody screening - ScienceDirect

Microfluidic single-cell technology in immunology and antibody screening -  ScienceDirect
Microfluidic single-cell technology in immunology and antibody screening - ScienceDirect

Cancer systems immunology | eLife
Cancer systems immunology | eLife

Antibody recycling by engineered pH-dependent antigen binding improves the  duration of antigen neutralization | Nature Biotechnology
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization | Nature Biotechnology

Frontiers | Factors Affecting Early Antibody Secreting Cell Maturation Into  Long-Lived Plasma Cells | Immunology
Frontiers | Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells | Immunology

Vaccine candidate discovery for the next generation of malaria vaccines -  Tuju - 2017 - Immunology - Wiley Online Library
Vaccine candidate discovery for the next generation of malaria vaccines - Tuju - 2017 - Immunology - Wiley Online Library

mRNA as novel technology for passive immunotherapy | SpringerLink
mRNA as novel technology for passive immunotherapy | SpringerLink

Frontiers | IgG Subclass Determines Suppression Versus Enhancement of  Humoral Alloimmunity to Kell RBC Antigens in Mice | Immunology
Frontiers | IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice | Immunology

PDF) Therapeutic antibodies for autoimmunity and inflammation
PDF) Therapeutic antibodies for autoimmunity and inflammation

Frontiers | Plasticity in Pro- and Anti-tumor Activity of Neutrophils:  Shifting the Balance | Immunology
Frontiers | Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance | Immunology

mRNA as novel technology for passive immunotherapy | SpringerLink
mRNA as novel technology for passive immunotherapy | SpringerLink

Cancer systems immunology | eLife
Cancer systems immunology | eLife

Lymph node choreography: B cells take the lead | Nature Immunology
Lymph node choreography: B cells take the lead | Nature Immunology

Cancer systems immunology | eLife
Cancer systems immunology | eLife

Tools to therapeutically harness the human antibody response | Nature  Reviews Immunology
Tools to therapeutically harness the human antibody response | Nature Reviews Immunology

PDF) Cancer systems immunology
PDF) Cancer systems immunology